MedTrace Logo

Screening and Treatment of Depression in the Community

NCT00430404 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 214

Last updated 2014-01-03

No results posted yet for this study

Summary

To evaluate the effectiveness of a community-based strategy of routine population mass screening for depression with follow-up feedback and management in a primary care non-psychiatric setting involving a structured, multifaceted, collaborative (primary care and hospital-based)shared care programme.

Hypotheses:

We hypothesize that a community-based early psychiatric interventional strategy (CEPIS) for depression in the elderly leads to increased recognition of depression by primary care physicians, more initiation of treatment for emotional problems, and improved outcomes for patients with depression, as measured by:

1. increased rates of detection or recognition by a primary care physician of minor or major (clinical) depression.
2. higher rates of management activities: counselling for psychological, family social problems, contact with community family services (human service agency), consultation and/or referral to a mental health specialist
3. Reduced depressive symptom severity, improved level of daily functioning and quality of life among those with major clinical depression
4. Better patient satisfaction with care
5. Favourable clinician's and patients perception of their usefulness or acceptability

Conditions

Interventions

OTHER

Collaborative care (Intervention)

Structured shared care with treatment protocol \& support

Sponsors & Collaborators

Principal Investigators

  • Ng Tz Pin, MD,MFPHM · Gerontological Research Programme, Faculty of Medicine, National University of Singapore

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2007-08-31
Completion
2007-09-30

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00430404 on ClinicalTrials.gov